Pregnancy-associated plasma protein-A (PAPP-A) in preovulatory, nonovulatory healthy, and atretic human ovarian follicles during the natural cycle. 1985

L Westergaard, and M J Sinosich, and J G Grudzinskas, and T Bolton, and K P McNatty, and D M Saunders, and B Teisner, and J Westergaard

UI MeSH Term Description Entries
D008598 Menstruation The periodic shedding of the ENDOMETRIUM and associated menstrual bleeding in the MENSTRUAL CYCLE of humans and primates. Menstruation is due to the decline in circulating PROGESTERONE, and occurs at the late LUTEAL PHASE when LUTEOLYSIS of the CORPUS LUTEUM takes place.
D010060 Ovulation The discharge of an OVUM from a rupturing follicle in the OVARY. Ovulations
D011257 Pregnancy Proteins Proteins produced by organs of the mother or the PLACENTA during PREGNANCY. These proteins may be pregnancy-specific (present only during pregnancy) or pregnancy-associated (present during pregnancy or under other conditions such as hormone therapy or certain malignancies.) Placental Proteins,Proteins, Placental,Proteins, Pregnancy
D011266 Pregnancy-Associated Plasma Protein-A A product of the PLACENTA, and DECIDUA, secreted into the maternal circulation during PREGNANCY. It has been identified as an IGF binding protein (IGFBP)-4 protease that proteolyzes IGFBP-4 and thus increases IGF bioavailability. It is found also in human FIBROBLASTS, ovarian FOLLICULAR FLUID, and GRANULOSA CELLS. The enzyme is a heterotetramer of about 500-kDa. PAPP-A,IGFBP-4 Metalloproteinase,IGFBP-4 Protease,IGFBP-4-Specific Proteinase,Insulin-Like Growth Factor-Dependent IGF Binding Protein-4 Protease,Insulin-Like-Growth Factor Binding Protein-4 Protease,PAPP-alpha,Pregnancy Associated alpha Plasma Protein,Pregnancy-Associated alpha-Plasma Protein,IGFBP 4 Metalloproteinase,IGFBP 4 Protease,Insulin Like Growth Factor Binding Protein 4 Protease,Insulin Like Growth Factor Dependent IGF Binding Protein 4 Protease,Metalloproteinase, IGFBP-4,PAPP alpha,Pregnancy Associated Plasma Protein A,Protease, IGFBP-4
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D005260 Female Females
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D005496 Follicular Atresia The degeneration and resorption of an OVARIAN FOLLICLE before it reaches maturity and ruptures. Atresia, Follicular,Atresias, Follicular,Follicular Atresias
D005498 Follicular Phase The period of the MENSTRUAL CYCLE representing follicular growth, increase in ovarian estrogen (ESTROGENS) production, and epithelial proliferation of the ENDOMETRIUM. Follicular phase begins with the onset of MENSTRUATION and ends with OVULATION. Menstrual Cycle, Follicular Phase,Menstrual Cycle, Proliferative Phase,Menstrual Proliferative Phase,Preovulatory Phase,Phase, Follicular,Phase, Menstrual Proliferative,Phase, Preovulatory,Proliferative Phase, Menstrual

Related Publications

L Westergaard, and M J Sinosich, and J G Grudzinskas, and T Bolton, and K P McNatty, and D M Saunders, and B Teisner, and J Westergaard
July 1981, The Journal of clinical endocrinology and metabolism,
L Westergaard, and M J Sinosich, and J G Grudzinskas, and T Bolton, and K P McNatty, and D M Saunders, and B Teisner, and J Westergaard
April 1984, Fertility and sterility,
L Westergaard, and M J Sinosich, and J G Grudzinskas, and T Bolton, and K P McNatty, and D M Saunders, and B Teisner, and J Westergaard
January 1982, Placenta. Supplement,
L Westergaard, and M J Sinosich, and J G Grudzinskas, and T Bolton, and K P McNatty, and D M Saunders, and B Teisner, and J Westergaard
October 2002, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society,
L Westergaard, and M J Sinosich, and J G Grudzinskas, and T Bolton, and K P McNatty, and D M Saunders, and B Teisner, and J Westergaard
November 1983, Journal of reproduction and fertility,
L Westergaard, and M J Sinosich, and J G Grudzinskas, and T Bolton, and K P McNatty, and D M Saunders, and B Teisner, and J Westergaard
May 2023, Scientific reports,
L Westergaard, and M J Sinosich, and J G Grudzinskas, and T Bolton, and K P McNatty, and D M Saunders, and B Teisner, and J Westergaard
November 2023, Endocrine reviews,
L Westergaard, and M J Sinosich, and J G Grudzinskas, and T Bolton, and K P McNatty, and D M Saunders, and B Teisner, and J Westergaard
December 1984, British journal of obstetrics and gynaecology,
L Westergaard, and M J Sinosich, and J G Grudzinskas, and T Bolton, and K P McNatty, and D M Saunders, and B Teisner, and J Westergaard
January 2014, Advances in clinical chemistry,
L Westergaard, and M J Sinosich, and J G Grudzinskas, and T Bolton, and K P McNatty, and D M Saunders, and B Teisner, and J Westergaard
December 2001, Endocrinology,
Copied contents to your clipboard!